China vs South-East Asia (WHO region): Cases started on MDR-TB treatment
China
13,984
in 2024
South-East Asia (WHO region)
57,653
in 2024
China rank
3rd
South-East Asia (WHO region) rank
3rd
Cases started on MDR-TB treatment over time
- China
- South-East Asia (WHO region)
How they compare
South-East Asia (WHO region) currently reports 57,653 against 13,984 in China, a difference of 43,669.
That makes South-East Asia (WHO region)'s figure about 4.1 times China's.
Across all 16 years both countries report, South-East Asia (WHO region) has been ahead every year.
China ranks 3rd and South-East Asia (WHO region) ranks 3rd of 193 countries.
South-East Asia (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 458 | 2,020 | 1,562 | South-East Asia (WHO region) |
| 2010s | 4,884 | 30,839 | 25,954 | South-East Asia (WHO region) |
| 2020s | 12,695 | 59,055 | 46,359 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, China or South-East Asia (WHO region)?
- South-East Asia (WHO region), at 57,653 against 13,984 in China as of 2024.
- What is the difference in cases started on mdr-tb treatment between China and South-East Asia (WHO region)?
- 43,669, with South-East Asia (WHO region) ahead.
- How many years of comparable data are there for China and South-East Asia (WHO region)?
- 16 years are reported by both, from 2009 to 2024.
- How do China and South-East Asia (WHO region) rank globally for cases started on mdr-tb treatment?
- China ranks 3rd and South-East Asia (WHO region) ranks 3rd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.